Validated across 14 peer-reviewed studies.

The initial paper demonstrating the validity of the Eyeonic system on a cohort of normal patients, used to generate the initial normative database (which was later expanded).

A study focused on the patient experience of the Eyeonic test which found a strong preference for Eyeonic over standard perimetry systems. 84% preferred Eyeonic to standard; preferred in 8 from 10 questionnaire items.

A formal validation study of the Eyeonic system compared to standard perimetry machines in a cohort of 225 patients. Eyeonic was found to have similar diagnostic capability to standard machines.

A study to define the validity and normative database for the Eyeonic 10-2 visual field protocol; basic test parameters and a normative database (which was later expanded) was established.

A study evaluating the test:retest repeatability of the Eyeonic system, important for meaningful progression monitoring. Acceptable test:retest repeatability was found, comparable with conventional machines.

This study expanded the Eyeonic normative cohort for an East Asian population. Test performance was similar in clinic and at home, with comparable outcomes to a Caucasian population.

An editorial explaining the Eyeonic system and its potential use to expand glaucoma care in Africa.

A clinical validation and comparison of the Eyeonic system to standard perimetry machines in the developing world setting. Patients from Vietnam performed testing repeatedly in clinic over 6 months. The test retained satisfactory accuracy and repeatability, similar to results from Australia.

This study evaluated 3 different portable perimetry systems including Eyeonic. All three were favourably reported by clinicians and patients alike. Eyeonic was favoured for home testing.

This study evaluated the consistency of testing across different monitors of different size, make and brand. It found a high level of consistency, repeatability and strong agreement despite different monitors.

This paper focused on home use of the Eyeonic system in a subpopulation of glaucoma patients in Vietnam over 6 months. Comparable results were observed between clinic and home OCCP at baseline. Acceptable consistency of home OCCP over 6 months was recognised.

A multicentre study evaluating the accuracy of home visual field testing for 55 people with glaucoma and controls, who performed 6 tests at home. Results were consistent, repeatable and in strong agreement with clinic results. Confirms the ability of Eyeonic to monitor glaucoma at home.

The study evaluated 60 glaucoma patients and 20 controls, finding strong accuracy, high sensitivity (96.97%) and excellent specificity (78.57%) when compared with standard machine perimeters, accurately predicting Australian driving criteria.

OCCP tablet shows strong correlation, agreement, and similar area-under-curve in identifying glaucomatous eyes from controls to both SAP and OCCP computer. Validates tablet use for clinical testing.

OCCP demonstrates consistent moderate agreement with SAP for mean deviation (MD), with similar reliability. As a potential screening and surveillance tool, OCCP could substantiate visual field testing in sub-Saharan Africa, especially where perimetry availability is limited.

Manuscript under review. PDF will be available on publication.